1373116-31-4

Basic information

• Product Name: 3-(N-(4-bromophenyl)-N-methylsulfamoyl)benzoic acid
• Synonyms: 3-(N-(4-bromophenyl)-N-methylsulfamoyl)benzoic acid
• CAS NO: 1373116-31-4
• Molecular Weight: 370.224
• Mol File: 1373116-31-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-(N-(4-bromophenyl)-N-methylsulfamoyl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(N-(4-bromophenyl)-N-methylsulfamoyl)benzoic acid(1373116-31-4)
• EPA Substance Registry System: 3-(N-(4-bromophenyl)-N-methylsulfamoyl)benzoic acid(1373116-31-4)

Safety Data

• Hazardous Substances Data: 1373116-31-4(Hazardous Substances Data)

Upstream product

• 65-85-0 benzoic acid 
• 6911-87-1 4-bromo-N-methylaniline 
• 4025-64-3 3-Carboxybenzenesulfonyl chloride 

Downstream Products

• 1586822-47-0 N-(5-chloropyridin-2-yl)-3-(N-(4-fluorophenyl)-N-methylsulfamoyl)benzamide 
• 1586822-88-9 3-(N-(4-bromophenyl)-N-methylsulfamoyl)-N-(5-hydroxypyridin-2-yl)benzamide 
• 1586822-86-7 3-(N-(4-bromophenyl)-N-methylsulfamoyl)-N-(5-fluoropyridin-2-yl)benzamide 
• 1586822-91-4 3-(N-(4-bromophenyl)-N-methylsulfamoyl)-N-(5-chlorothiazol-2-yl)benzamide 
• 1586822-87-8 3-(N-(4-bromophenyl)-N-methylsulfamoyl)-N-(5-methoxypyridin-2-yl)benzamide 
• 1586822-89-0 3-(N-(4-bromophenyl)-N-methylsulfamoyl)-N-(6-chloropyridazin-3-yl)benzamide 
• 1586822-85-6 3-(N-(4-bromophenyl)-N-methylsulfamoyl)-N-(5-chloropyridin-2-yl)benzamide 
• 1373116-27-8 N-(4-bromophenyl)-3-(N-(4-bromophenyl)-N-methylsulfamoyl)benzamide 
• 1373116-24-5 3-(N-(4-bromophenyl)-N-methylsulfamoyl)-N-methyl-N-(4-(trifluoromethyl)phenyl)benzamide 
• 1373116-22-3 3-(N-(4-bromophenyl)-N-methylsulfamoyl)-N-(4-chlorophenyl)-N-methylbenzamide 
• 1373116-23-4 3-(N-(4-bromophenyl)-N-methylsulfamoyl)-N-(4-fluorophenyl)-N-methylbenzamide 

Relevant articles and documents

BENZAMIDE COMPOUNDS AND RELATED METHODS OF USE

Benzamide compounds and derivatives thereof, as can be used for selective inhibition of the SIRT2 enzyme and/or therapeutic use in the treatment of Huntington's disease.

3-(N-Arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2)

Inhibition of sirtuin 2 (SIRT2) is known to be protective against the toxicity of disease proteins in Parkinson's and Huntington's models of neurodegeneration. Previously, we developed SIRT2 inhibitors based on the 3-(N-arylsulfamoyl)benzamide scaffold, i